Genetic causes of type 2 diabetes

Global Diabetes Drug Intelligence Center Database 2021 - Featuring Astellas, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 8, 2021
Health, General Health, Habit, Genetic causes of type 2 diabetes, Type 2 diabetes, Population, Novo Nordisk, Prevalence, Type 1 diabetes, Sanofi, USD, Diabetes, Biocon, CAGR, Eli Lilly, T2DM, Urbanization, Obesity, Pharmaceutical industry

However, due to high competitions in the local markets, consumer penetration for their products is being worked on continuously.

Key Points: 
  • However, due to high competitions in the local markets, consumer penetration for their products is being worked on continuously.
  • Global Rise in Diabetic Population:
    There has been a tremendous increase in the diabetic population levels globally, over the last decade.
  • It is estimated that out of the total 415 million people suffering from diabetes worldwide, 46% of this demographic is those with undiagnosed diabetes.
  • Biocon is developing Insulin Tregopil, an oral prandial insulin tablet, for the treatment of Type-1 and Type-2 diabetes mellitus.

Genetic Technologies Reports Q1 FY22 Results

Retrieved on: 
Monday, October 25, 2021
Woman, Genetypes, Colorectal cancer, Polygene, IBX, Ovarian cancer, Epidemiology, Marketing, National, ASX, COVID-19, Colditz, NATA, Health, Acquisition, GLOBE, Research, DTC, National public health institutes, Completeness, Company, Direct, Norwegian Institute of Public Health, Institute, Coronary artery disease, European, IBX Group, Risk, Public health, Genetic causes of type 2 diabetes, Awareness, PLOS, Biobank, Population, GTG, Breast cancer, Single-nucleotide polymorphism, Cancer, Certification, NASDAQ, CIT, Applied Genetic Technologies Corporation, Board, Washington University in St. Louis, Roy Taylor (scientist), Type 2 diabetes, Prostate cancer, UK Biobank, Agriculture, Pharmaceutical industry, Fine chemical, Video game, Medical device, Birth control

The Multi-Test is a Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.

Key Points: 
  • The Multi-Test is a Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.
  • Phase one launch to include Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Coronary Artery Disease and Type-2 Diabetes.
  • Commenting on the quarter, CEO Simon Morriss stated: This past quarter demonstrates the forward trajectory and momentum Genetic Technologies has established.
  • Authorised for release by the Board of Genetic Technologies Limited.

Groundbreaking DIABETESpredict® - Predictive Genetic Test for Diabetes Now Available in the US

Retrieved on: 
Wednesday, July 31, 2019
Organ systems, Endocrine system, Endocrinology, Diabetes, Type 2 diabetes, Genetic causes of type 2 diabetes, Gestational diabetes

GREENVILLE, S.C., July 31, 2019 /PRNewswire/ -- Premier Medical Laboratory Services is now offeringthe revolutionary DIABETESpredict test to the US, expected to mark a new era in diabetes prevention and care.The first ever predictive genetic test for type 2 diabetes, it evaluates the risk of the disease onset by examining individual genetic profiles.

Key Points: 
  • GREENVILLE, S.C., July 31, 2019 /PRNewswire/ -- Premier Medical Laboratory Services is now offeringthe revolutionary DIABETESpredict test to the US, expected to mark a new era in diabetes prevention and care.The first ever predictive genetic test for type 2 diabetes, it evaluates the risk of the disease onset by examining individual genetic profiles.
  • Test results of DIABETESpredict reveal whether a patient is at a high, medium or low risk of suffering from type 2 diabetes.
  • In addition, the DIABETESpredict results report provides individualized diet, exercise and lifestyle recommendations informed by the genetic profile detected in each person.
  • Altogether such studies collected information from more than 110,000 diabetic and non-diabetic people to identify the genetic variants most associated with Type 2 diabetes."